The Trump administration is planning an Affordable Care Act replacement plan; a drug-resistant fungus has been spreading and causing severe issues for hospitals; protesters gather in Washington, DC, to criticize the FDA's handling of the opioid crisis.
Mick Mulvaney, acting White House chief of staff, says the Trump administration will release a plan to replace the Affordable Care Act “fairly shortly,” CNN reported. HHS Secretary Alex Azar and CMS Administrator Seema Verma joined White House aides and administration officials at Camp David on Saturday to outline the next moves for Trump’s healthcare proposal. Topics discussed included lowering drug prices, individual health insurance marketplaces, and messaging strategies. Mulvaney told Fox News Sunday believes the plan under development will provide GOP candidates with a plan they can discuss with voters while campaigning.
Infections caused by the fungus Candida auris, which affects people with weakened immune systems and is resistant to antifungal medications, have been quietly spreading around the world for over 5 years, The New York Times reported. The fungus was recently reported in New York, New Jersey, and Illinois after causing serious issues in Venezuela, Spain, Great Britain, India, Pakistan, and South Africa. The invasive fungus was found everywhere in the room of a patient who passed away at New York's Mount Sinai Hospital from a related infection after being hospitalized for 90 days. The hospital required special cleaning equipment and had to replace floor and ceiling tiles to fully eliminate the fungus.
Nearly 100 protesters gathered Friday in Washington, DC, to protest Scott Gottlieb, MD, on his final Day as FDA commissioner with an 800-pound heroin spoon stamped with the FDA’s logo, STAT News reported. The group called for the FDA to stop approving opioids and urged the agency to shift its focus towards encouraging the development of more drugs to treat addiction. The protesters’ chant echoed “200 dead every day, we blame the FDA.” However, the group delivered the spoon to the HHS headquarters, the Hubert H. Humphrey Building in Washington, DC, not the FDA complex in Silver Spring, Maryland.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen